ArticleMolecular oncology2019

Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.

Gustav Steinemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.